The U.S. Food and Drug Administration (FDA) is taking action to remove ingestible fluoride prescription drugs for children from the market, citing significant health risks for infants and toddlers.
In a recent press release, the FDA emphasized that swallowed fluoride products pose more risks than toothpaste or fluoride rinses, which are generally used topically. The agency noted that fluoride ingestion can lead to several health concerns, including developmental issues with the gut microbiome, thyroid disorders, weight gain, and decreased IQ in children.
The FDA pointed to multiple studies linking fluoride ingestion with adverse effects on children’s health. Notably, a meta-analysis of various studies found an inverse relationship between fluoride levels in urine and drinking water and children’s IQ, raising significant concerns about the impact of fluoride on cognitive development.
Related topics:
